Dan Grandér

9.5k total citations · 1 hit paper
125 papers, 6.5k citations indexed

About

Dan Grandér is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Dan Grandér has authored 125 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 53 papers in Oncology and 30 papers in Immunology. Recurrent topics in Dan Grandér's work include Chronic Lymphocytic Leukemia Research (23 papers), Cytokine Signaling Pathways and Interactions (23 papers) and Cancer-related Molecular Pathways (19 papers). Dan Grandér is often cited by papers focused on Chronic Lymphocytic Leukemia Research (23 papers), Cytokine Signaling Pathways and Interactions (23 papers) and Cancer-related Molecular Pathways (19 papers). Dan Grandér collaborates with scholars based in Sweden, United States and United Kingdom. Dan Grandér's co-authors include Stefan Einhorn, Per Johnsson, Katja Pokrovskaja Tamm, Kevin V. Morris, Martin Corcoran, Olle Sangfelt, Theocharis Panaretakis, Leonard Lipovich, Mats Heyman and Sven Erickson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Dan Grandér

123 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolutionary conservation of long non-coding RNAs; sequence, structure, function

2013 536 citations Per Johnsson, Dan Grandér et al. profile →

Peers

Countries citing papers authored by Dan Grandér

Since Specialization

Citations

This map shows the geographic impact of Dan Grandér's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Grandér with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Grandér more than expected).

Fields of papers citing papers by Dan Grandér

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Grandér. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Grandér. The network helps show where Dan Grandér may publish in the future.

Co-authorship network of co-authors of Dan Grandér

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Grandér. A scholar is included among the top collaborators of Dan Grandér based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Grandér. Dan Grandér is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells 2017 ·Cancer Immunology Research ·Lisa L. Liu, Vivien Béziat, Vincent Yi Sheng Oei, Aline Pfefferle, Marie Schaffer, Sören Lehmann, Eva Hellström‐Lindberg, Stefan Söderhäll, Mats Heyman, Dan Grandér, Karl‐Johan Malmberg	61
2	MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC 2016 ·Journal of Investigative Dermatology ·Warangkana Lohcharoenkal, Masako Harada, Jakob Lovén, Florian Meisgen, Ning Xu, Lingyun Zhang, Jan Lapins, (unknown), (unknown), Liisa Nissinen, Veli‐Matti Kähäri, Mona Ståhle, Enikö Sonkoly, Dan Grandér, Marie Arsenian‐Henriksson, Andor Pivarcsi	32
3	Pseudogene-Expressed RNAs: Emerging Roles in Gene Regulation and Disease 2015 ·Current topics in microbiology and immunology ·Dan Grandér, Per Johnsson	49
4	TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity 2013 ·British Journal of Haematology ·Moshe E. Gatt, Kohichi Takada, Mala Mani, Mikael Lerner, Marjorie Pick, Teru Hideshima, Daniel E. Carrasco, Alexei Protopopov, Elena V. Ivanova, Olle Sangfelt, Dan Grandér, Bart Barlogie, John D. Shaughnessy, Kenneth C. Anderson, Daniel R. Carrasco	24
5	MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor δ in human monocytes during the inflammatory response 2013 ·International Journal of Molecular Medicine ·Petra Thulin, Tianling Wei, (unknown), L.K. Cheung, Rachel M. Fisher, Dan Grandér, Martin Corcoran, Ewa Ehrenborg	73
6	Sorafenib Has Potent Antitumor Activity against Multiple Myeloma In Vitro , Ex Vivo , and In Vivo in the 5T33MM Mouse Model 2012 ·Cancer Research ·Pedram Kharaziha, Hendrik De Raeve, (unknown), Qiao Li, Astrid Gruber, Per Johnsson, Georgia Kokaraki, (unknown), Edward Laane, Anders Österborg, Boris Zhivotovsky, Helena Jernberg‐Wiklund, Dan Grandér, Fredrik Celsing, Magnus Björkholm, Karin Vanderkerken, Theocharis Panaretakis	42
7	Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies 2012 ·Leukemia & lymphoma ·Amir Hossein Daneshmanesh, Anna Porwit, Mohammad Hojjat‐Farsangi, Mahmood Jeddi‐Tehrani, Katja Pokrovskaja Tamm, Dan Grandér, Sören Lehmann, Stefan Norin, Fazel Shokri, Hodjattallah Rabbani, Håkan Mellstedt, Anders Österborg	63
8	Requirement of Apoptotic Protease-Activating Factor-1 for Bortezomib-Induced Apoptosis but Not for Fas-Mediated Apoptosis in Human Leukemic Cells 2012 ·Molecular Pharmacology ·(unknown), Rebecca Ceder, Giulio Preta, Katja Pokrovskaja Tamm, Roland Grafström, Mats Heyman, Stefan Söderhäll, Dan Grandér, Ingrid Hedenfalk, John D. Robertson, Bengt Fadeel	9
9	MicroRNA-125b Down-regulates Matrix Metallopeptidase 13 and Inhibits Cutaneous Squamous Cell Carcinoma Cell Proliferation, Migration, and Invasion 2012 ·Journal of Biological Chemistry ·Ning Xu, Lingyun Zhang, Florian Meisgen, Masako Harada, Johan Heilborn, Bernhard Homey, Dan Grandér, Mona Ståhle, Enikö Sonkoly, Andor Pivarcsi	150
10	Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies 2009 ·Autophagy ·Dan Grandér, Pedram Kharaziha, Edward Laane, Katja Pokrovskaja Tamm, Theocharis Panaretakis	54
11	The Tumor Suppressor Gene hCDC4 Is Frequently Mutated in Human T-Cell Acute Lymphoblastic Leukemia with Functional Consequences for Notch Signaling 2007 ·Cancer Research ·Alena Malyukova, Takeaki Dohda, Natalie von der Lehr, (unknown), Martin Corcoran, Mats Heyman, Charles Spruck, Dan Grandér, Urban Lendahl, Olle Sangfelt	148
12	Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members 2007 ·Haematologica ·Edward Laane, Theocharis Panaretakis, Katja Pokrovskaja Tamm, Eva Buentke, Martin Corcoran, (unknown), Mats Heyman, Joanna Mazur, Boris Zhivotovsky, Anna Porwit, Dan Grandér	49
13	The HPV-16 E7 Oncogene Sensitizes Malignant Cells to IFN-α-Induced Apoptosis 2005 ·Journal of Interferon & Cytokine Research ·Lena Thyrell, Olle Sangfelt, Boris Zhivotovsky, Katja Pokrovskaja Tamm, Yisong Wang, Stefan Einhorn, Dan Grandér	8
14	Alternative Signaling Pathways Regulating Type I Interferon-Induced Apoptosis 2005 ·Journal of Interferon & Cytokine Research ·Katja Pokrovskaja Tamm, Theocharis Panaretakis, Dan Grandér	40
15	Doxorubicin Requires the Sequential Activation of Caspase-2, Protein Kinase Cδ, and c-Jun NH₂-terminal Kinase to Induce Apoptosis 2005 ·Molecular Biology of the Cell ·Theocharis Panaretakis, Edward Laane, Katja Pokrovskaja Tamm, (unknown), Aristidis Moustakas, Boris Zhivotovsky, Mats Heyman, Maria C. Shoshan, Dan Grandér	92
16	Interferon α-induced Apoptosis in Tumor Cells Is Mediated through the Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Signaling Pathway 2004 ·Journal of Biological Chemistry ·Lena Thyrell, (unknown), Velmurugesan Arulampalam, Theocharis Panaretakis, Sabine Uhles, Markus Dagnell, Boris Zhivotovsky, Ingo B. Leibiger, Dan Grandér, Katja Pokrovskaja Tamm	98
17	Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92 2002 ·Leukemia ·(unknown), Göran Gustafsson, Stanislaw Garwicz, Dan Grandér, (unknown), B‐M Frost, Anne Mäkipernaa, Omid Rasool, (unknown), Kjeld Schmiegelow, (unknown), Kim Vettenranta, Finn Wesenberg, Stefan Einhorn, Mats Heyman	26
18	How Does Interferon-Alpha Exert Its Antitumour Activity in Multiple Myeloma? 2000 ·Acta Oncologica ·Dan Grandér	16
19	Chromosome 13q14 deletions in lymphoid malignancies 1996 ·Data Archiving and Networked Services (DANS) ·(unknown), (unknown), (unknown), Dan Grandér, Gösta Gahrton, Gunnar Juliusson, (unknown), (unknown), N. K. Yankovsky, (unknown)	1
20	Measurement of interferon sensitivity in tumour cells from fine-needle aspirations 1992 ·European Journal of Cancer ·Dan Grandér, Lambert Skoog, Edneia Tani, Stefan Einhorn	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact